Katie Capps on integrating pharmacogenomic testing into the CMM process

Published: Dec. 10, 2020, 2:34 a.m.

b'Katherine (Katie) Capps, Co-Founder & Executive Director of the GTMRx Institute as well as Founder & President of Health2 Resources, joined us in this episode of Precision Insights to discuss what comprehensive medication management (CMM) is, and how pharmacogenetics can be used in the CMM process.'